GSK
Five charged in US for scheme to steal GSK secrets
January 21, 2016Research and Development China, GSK, employee theft, trade secrets
Five people have been charged in the US for a scheme to steal secrets from British drugmaker GlaxoSmithKline and then …
GSK explains decision to halt payments to doctors
January 8, 2016Medical Communications, Sales and Marketing GSK, doctor payments, medical education, transparency
GSK has put into practice its pledge to halt payments to doctors to promote its products at medical seminars – …
Investment group renews calls for GSK to split
January 8, 2016Medical Communications, Sales and Marketing GSK, Neil Woodford, investment, restructure
Multi-million pound fund manager Neil Woodford has renewed his call for GSK to break up into separate business units, amid …
PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board
January 7, 2016Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology
Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …
Researchers question price of GSK’s Nucala
December 23, 2015Research and Development GSK, HEOR, ICER, Nucala, asthma, cost-effective, health economics, health economics outcomes research
GSK is charging up to four times more for its recently approved asthma drug Nucala than is justified by cost-effectiveness …
Amgen buys back rights to three drugs from GSK
December 15, 2015Research and Development, Sales and Marketing Amgen, GSK
Amgen has announced that it will reacquire the rights to three products in 48 countries from GSK, as it seeks …
GSK in malaria collaboration with Comic Relief
December 15, 2015Manufacturing and Production Comic Relief, GSK, corporate social responsibility, csr, malaria
GSK and UK-based charity Comic Relief have launched a five-year partnership to fight malaria and improve health in five countries …
Which are pharma’s most innovative companies?
December 11, 2015Medical Communications, Research and Development GSK, Roche, research and development
It has been a record-breaking year for the pharmaceutical industry in terms of deals, but what about the underlying innovation …
GSK collaborates on ‘smart inhaler’ technology for respiratory trials
December 3, 2015Research and Development COPD, GSK, Propeller, Propeller Health, asthma, clinical trials, ellipta, inhalers, smart drugs, smart inhalers
GSK has entered the ‘smart drug’ industry by partnering with a health technology company to develop a sensor for use …
GSK gets European approval for asthma treatment Nucala
December 3, 2015Research and Development GSK, Nucala, asthma
GlaxoSmithKline has received marketing authorisation from the European Commission for Nucala as an add-on treatment for severe refractory eosinophilic asthma …
GSK begins Phase III study of sirukumab in giant cell arteritis
November 26, 2015Business Services, Research and Development, Sales and Marketing GSK, Janssen
GSK today announced it has begun a Phase III study evaluating sirukumab, a human anti-interleukin (IL)-6 monoclonal antibody, for the …
GSK ready for lupus drug push
November 12, 2015Manufacturing and Production, Research and Development, Sales and Marketing Benlysta, GSK, Lupus, SLE, belimumab, systemic lupus erythematosus
Having presented positive late-stage results for a new formulation of its inflammatory drug Benlysta, GSK says it will file supplementary …
MSF launches global action against GSK and Pfizer over pneumonia vaccine price
November 12, 2015Manufacturing and Production, Sales and Marketing Doctors Without Borders, GSK, MSF, Médecins Sans Frontières, Pfizer, Synflorix, pneumococcal vaccine, pneumonia, prevenar 13, vaccines
International medical aid charity Médecins Sans Frontières/Doctors Without Borders (MSF) is taking action against GlaxoSmithKline and Pfizer, calling on the …
GSK asthma drug Nucala gets FDA approval
November 6, 2015GSK, Nucala, asthma, eosinophils, mepolizumab
GlaxoSmithKline has received approval from the FDA for Nucala as an add-on maintenance treatment of patients with severe asthma aged …
GSK plots return to growth with launch of 20 new drugs by 2020
November 4, 2015Research and Development, Sales and Marketing GSK, Sir Andrew Witty, financial results, product pipeline
GSK has set out plans to boost its flagging performance with the launch of up to 20 new drugs by …
Latest content
ESTEVE CDMO adds $17.5m to Illinois expansion
Brenntag and dsm-firmenich expand biopharma vitamin partnership
